Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
GATA2
|
ENSG00000179348.7 | GATA binding protein 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GATA2 | hg19_v2_chr3_-_128212016_128212051 | 0.40 | 2.8e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_51456321 | 1.60 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
chr19_-_51456344 | 1.50 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
chr17_+_4853442 | 1.49 |
ENST00000522301.1
|
ENO3
|
enolase 3 (beta, muscle) |
chr10_+_118187379 | 1.45 |
ENST00000369230.3
|
PNLIPRP3
|
pancreatic lipase-related protein 3 |
chr18_-_29340827 | 1.40 |
ENST00000269205.5
|
SLC25A52
|
solute carrier family 25, member 52 |
chr19_-_51466681 | 1.37 |
ENST00000456750.2
|
KLK6
|
kallikrein-related peptidase 6 |
chr18_-_31628558 | 1.26 |
ENST00000535384.1
|
NOL4
|
nucleolar protein 4 |
chr1_+_150480576 | 1.22 |
ENST00000346569.6
|
ECM1
|
extracellular matrix protein 1 |
chr2_-_235405168 | 1.18 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
chr12_-_8815215 | 1.13 |
ENST00000544889.1
ENST00000543369.1 |
MFAP5
|
microfibrillar associated protein 5 |
chr11_-_19082216 | 1.08 |
ENST00000329773.2
|
MRGPRX2
|
MAS-related GPR, member X2 |
chr18_-_31802056 | 1.04 |
ENST00000538587.1
|
NOL4
|
nucleolar protein 4 |
chr10_-_79397391 | 1.04 |
ENST00000286628.8
ENST00000406533.3 ENST00000354353.5 ENST00000404857.1 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr1_+_116654376 | 1.03 |
ENST00000369500.3
|
MAB21L3
|
mab-21-like 3 (C. elegans) |
chr19_+_917287 | 1.02 |
ENST00000592648.1
ENST00000234371.5 |
KISS1R
|
KISS1 receptor |
chr1_+_120839412 | 0.99 |
ENST00000355228.4
|
FAM72B
|
family with sequence similarity 72, member B |
chr1_+_74701062 | 0.99 |
ENST00000326637.3
|
TNNI3K
|
TNNI3 interacting kinase |
chr17_-_15501932 | 0.97 |
ENST00000583965.1
|
CDRT1
|
CMT1A duplicated region transcript 1 |
chr4_+_75310851 | 0.96 |
ENST00000395748.3
ENST00000264487.2 |
AREG
|
amphiregulin |
chr2_+_219472488 | 0.95 |
ENST00000450993.2
|
PLCD4
|
phospholipase C, delta 4 |
chr12_-_8815299 | 0.95 |
ENST00000535336.1
|
MFAP5
|
microfibrillar associated protein 5 |
chr19_-_51487071 | 0.92 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
chr16_-_55867146 | 0.90 |
ENST00000422046.2
|
CES1
|
carboxylesterase 1 |
chr4_-_159956333 | 0.88 |
ENST00000434826.2
|
C4orf45
|
chromosome 4 open reading frame 45 |
chr5_+_148521136 | 0.88 |
ENST00000506113.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
chr1_+_152957707 | 0.87 |
ENST00000368762.1
|
SPRR1A
|
small proline-rich protein 1A |
chr12_-_52779433 | 0.87 |
ENST00000257951.3
|
KRT84
|
keratin 84 |
chr2_+_113885138 | 0.86 |
ENST00000409930.3
|
IL1RN
|
interleukin 1 receptor antagonist |
chr3_-_47950745 | 0.86 |
ENST00000429422.1
|
MAP4
|
microtubule-associated protein 4 |
chr11_-_125366089 | 0.86 |
ENST00000366139.3
ENST00000278919.3 |
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
chr5_+_147691979 | 0.85 |
ENST00000274565.4
|
SPINK7
|
serine peptidase inhibitor, Kazal type 7 (putative) |
chr11_+_57310114 | 0.85 |
ENST00000527972.1
ENST00000399154.2 |
SMTNL1
|
smoothelin-like 1 |
chr1_-_153521714 | 0.80 |
ENST00000368713.3
|
S100A3
|
S100 calcium binding protein A3 |
chr3_-_74570291 | 0.79 |
ENST00000263665.6
|
CNTN3
|
contactin 3 (plasmacytoma associated) |
chr11_+_35201826 | 0.79 |
ENST00000531873.1
|
CD44
|
CD44 molecule (Indian blood group) |
chr1_-_153521597 | 0.78 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
chr12_-_95510743 | 0.78 |
ENST00000551521.1
|
FGD6
|
FYVE, RhoGEF and PH domain containing 6 |
chr5_+_169780485 | 0.77 |
ENST00000377360.4
|
KCNIP1
|
Kv channel interacting protein 1 |
chr1_+_84630053 | 0.74 |
ENST00000394838.2
ENST00000370682.3 ENST00000432111.1 |
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr6_-_131277510 | 0.74 |
ENST00000525193.1
ENST00000527659.1 |
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
chr18_-_31802282 | 0.73 |
ENST00000535475.1
|
NOL4
|
nucleolar protein 4 |
chr2_+_201994569 | 0.71 |
ENST00000457277.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr4_-_57547454 | 0.71 |
ENST00000556376.2
|
HOPX
|
HOP homeobox |
chr4_+_154073469 | 0.71 |
ENST00000441616.1
|
TRIM2
|
tripartite motif containing 2 |
chr8_-_87081926 | 0.69 |
ENST00000276616.2
|
PSKH2
|
protein serine kinase H2 |
chr11_+_111126707 | 0.69 |
ENST00000280325.4
|
C11orf53
|
chromosome 11 open reading frame 53 |
chr11_-_119599794 | 0.69 |
ENST00000264025.3
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
chr6_-_167571817 | 0.67 |
ENST00000366834.1
|
GPR31
|
G protein-coupled receptor 31 |
chr2_-_208030647 | 0.67 |
ENST00000309446.6
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
chr5_-_39270725 | 0.67 |
ENST00000512138.1
ENST00000512982.1 ENST00000540520.1 |
FYB
|
FYN binding protein |
chr5_-_76788317 | 0.66 |
ENST00000296679.4
|
WDR41
|
WD repeat domain 41 |
chr18_+_61442629 | 0.65 |
ENST00000398019.2
ENST00000540675.1 |
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
chr1_-_153066998 | 0.65 |
ENST00000368750.3
|
SPRR2E
|
small proline-rich protein 2E |
chr13_+_98605902 | 0.64 |
ENST00000460070.1
ENST00000481455.1 ENST00000261574.5 ENST00000493281.1 ENST00000463157.1 ENST00000471898.1 ENST00000489058.1 ENST00000481689.1 |
IPO5
|
importin 5 |
chr6_-_41130841 | 0.64 |
ENST00000373122.4
|
TREM2
|
triggering receptor expressed on myeloid cells 2 |
chr1_+_180165672 | 0.64 |
ENST00000443059.1
|
QSOX1
|
quiescin Q6 sulfhydryl oxidase 1 |
chr3_+_111718173 | 0.64 |
ENST00000494932.1
|
TAGLN3
|
transgelin 3 |
chr4_-_48136217 | 0.64 |
ENST00000264316.4
|
TXK
|
TXK tyrosine kinase |
chr4_+_71200681 | 0.63 |
ENST00000273936.5
|
CABS1
|
calcium-binding protein, spermatid-specific 1 |
chr4_-_140544386 | 0.62 |
ENST00000561977.1
|
RP11-308D13.3
|
RP11-308D13.3 |
chr12_+_75874460 | 0.62 |
ENST00000266659.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr19_-_1650666 | 0.62 |
ENST00000588136.1
|
TCF3
|
transcription factor 3 |
chr4_-_48082192 | 0.62 |
ENST00000507351.1
|
TXK
|
TXK tyrosine kinase |
chr12_-_10978957 | 0.62 |
ENST00000240619.2
|
TAS2R10
|
taste receptor, type 2, member 10 |
chr12_-_57328187 | 0.62 |
ENST00000293502.1
|
SDR9C7
|
short chain dehydrogenase/reductase family 9C, member 7 |
chr4_-_111119804 | 0.62 |
ENST00000394607.3
ENST00000302274.3 |
ELOVL6
|
ELOVL fatty acid elongase 6 |
chr4_-_57547870 | 0.61 |
ENST00000381260.3
ENST00000420433.1 ENST00000554144.1 ENST00000557328.1 |
HOPX
|
HOP homeobox |
chr12_+_15699286 | 0.60 |
ENST00000442921.2
ENST00000542557.1 ENST00000445537.2 ENST00000544244.1 |
PTPRO
|
protein tyrosine phosphatase, receptor type, O |
chr1_-_153085984 | 0.60 |
ENST00000468739.1
|
SPRR2F
|
small proline-rich protein 2F |
chrX_+_69488174 | 0.59 |
ENST00000480877.2
ENST00000307959.8 |
ARR3
|
arrestin 3, retinal (X-arrestin) |
chr7_-_141957847 | 0.59 |
ENST00000552471.1
ENST00000547058.2 |
PRSS58
|
protease, serine, 58 |
chr21_-_31869451 | 0.59 |
ENST00000334058.2
|
KRTAP19-4
|
keratin associated protein 19-4 |
chr1_-_24469602 | 0.58 |
ENST00000270800.1
|
IL22RA1
|
interleukin 22 receptor, alpha 1 |
chr8_-_42623747 | 0.57 |
ENST00000534622.1
|
CHRNA6
|
cholinergic receptor, nicotinic, alpha 6 (neuronal) |
chr1_+_17559776 | 0.57 |
ENST00000537499.1
ENST00000413717.2 ENST00000536552.1 |
PADI1
|
peptidyl arginine deiminase, type I |
chr10_-_79397316 | 0.57 |
ENST00000372421.5
ENST00000457953.1 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr9_+_131102925 | 0.57 |
ENST00000372870.1
ENST00000300456.4 |
SLC27A4
|
solute carrier family 27 (fatty acid transporter), member 4 |
chr10_+_99349450 | 0.57 |
ENST00000370640.3
|
C10orf62
|
chromosome 10 open reading frame 62 |
chr1_+_159557607 | 0.56 |
ENST00000255040.2
|
APCS
|
amyloid P component, serum |
chr17_+_77019030 | 0.56 |
ENST00000580454.1
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr11_-_107729887 | 0.55 |
ENST00000525815.1
|
SLC35F2
|
solute carrier family 35, member F2 |
chr8_+_54764346 | 0.55 |
ENST00000297313.3
ENST00000344277.6 |
RGS20
|
regulator of G-protein signaling 20 |
chr9_+_90112117 | 0.55 |
ENST00000358077.5
|
DAPK1
|
death-associated protein kinase 1 |
chr16_+_30064444 | 0.54 |
ENST00000395248.1
ENST00000566897.1 ENST00000568435.1 |
ALDOA
|
aldolase A, fructose-bisphosphate |
chr2_-_89247338 | 0.54 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr3_-_51813009 | 0.54 |
ENST00000398780.3
|
IQCF6
|
IQ motif containing F6 |
chr16_-_32688053 | 0.54 |
ENST00000398682.4
|
TP53TG3
|
TP53 target 3 |
chr7_-_99527243 | 0.54 |
ENST00000312891.2
|
GJC3
|
gap junction protein, gamma 3, 30.2kDa |
chr8_-_133123406 | 0.53 |
ENST00000434736.2
|
HHLA1
|
HERV-H LTR-associating 1 |
chr10_-_79397479 | 0.53 |
ENST00000404771.3
|
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr7_+_55177416 | 0.53 |
ENST00000450046.1
ENST00000454757.2 |
EGFR
|
epidermal growth factor receptor |
chr2_+_210444142 | 0.53 |
ENST00000360351.4
ENST00000361559.4 |
MAP2
|
microtubule-associated protein 2 |
chr10_+_135340859 | 0.53 |
ENST00000252945.3
ENST00000421586.1 ENST00000418356.1 |
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1 |
chr2_-_8464760 | 0.53 |
ENST00000430192.1
|
LINC00299
|
long intergenic non-protein coding RNA 299 |
chr19_+_41869894 | 0.52 |
ENST00000413014.2
|
TMEM91
|
transmembrane protein 91 |
chr6_-_39290744 | 0.52 |
ENST00000507712.1
|
KCNK16
|
potassium channel, subfamily K, member 16 |
chr12_-_4553385 | 0.52 |
ENST00000543077.1
|
FGF6
|
fibroblast growth factor 6 |
chr2_-_89310012 | 0.52 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr11_-_11747257 | 0.51 |
ENST00000601641.1
|
AC131935.1
|
AC131935.1 |
chrX_+_69509927 | 0.51 |
ENST00000374403.3
|
KIF4A
|
kinesin family member 4A |
chr8_-_27695552 | 0.50 |
ENST00000522944.1
ENST00000301905.4 |
PBK
|
PDZ binding kinase |
chr1_+_153003671 | 0.50 |
ENST00000307098.4
|
SPRR1B
|
small proline-rich protein 1B |
chr12_-_53594227 | 0.50 |
ENST00000550743.2
|
ITGB7
|
integrin, beta 7 |
chr1_-_20141763 | 0.50 |
ENST00000375121.2
|
RNF186
|
ring finger protein 186 |
chr1_-_150780757 | 0.50 |
ENST00000271651.3
|
CTSK
|
cathepsin K |
chr1_+_84630645 | 0.50 |
ENST00000394839.2
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr11_-_5537920 | 0.50 |
ENST00000380184.1
|
UBQLNL
|
ubiquilin-like |
chr7_-_142139783 | 0.49 |
ENST00000390374.3
|
TRBV7-6
|
T cell receptor beta variable 7-6 |
chr11_+_5410607 | 0.49 |
ENST00000328611.3
|
OR51M1
|
olfactory receptor, family 51, subfamily M, member 1 |
chr3_+_188889737 | 0.49 |
ENST00000345063.3
|
TPRG1
|
tumor protein p63 regulated 1 |
chr2_+_114163945 | 0.49 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
chr1_-_54303949 | 0.49 |
ENST00000234725.8
|
NDC1
|
NDC1 transmembrane nucleoporin |
chr7_-_38370536 | 0.48 |
ENST00000390343.2
|
TRGV8
|
T cell receptor gamma variable 8 |
chr2_-_24307162 | 0.48 |
ENST00000413037.1
ENST00000407482.1 |
TP53I3
|
tumor protein p53 inducible protein 3 |
chr8_+_99956759 | 0.48 |
ENST00000522510.1
ENST00000457907.2 |
OSR2
|
odd-skipped related transciption factor 2 |
chr1_-_161519579 | 0.47 |
ENST00000426740.1
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr3_-_24207039 | 0.46 |
ENST00000280696.5
|
THRB
|
thyroid hormone receptor, beta |
chr15_-_74501360 | 0.46 |
ENST00000323940.5
|
STRA6
|
stimulated by retinoic acid 6 |
chr15_-_23932437 | 0.46 |
ENST00000331837.4
|
NDN
|
necdin, melanoma antigen (MAGE) family member |
chr12_+_75874580 | 0.46 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr19_-_4723761 | 0.46 |
ENST00000597849.1
ENST00000598800.1 ENST00000602161.1 ENST00000597726.1 ENST00000601130.1 ENST00000262960.9 |
DPP9
|
dipeptidyl-peptidase 9 |
chr7_-_107642348 | 0.46 |
ENST00000393561.1
|
LAMB1
|
laminin, beta 1 |
chr1_-_113160826 | 0.46 |
ENST00000538187.1
ENST00000369664.1 |
ST7L
|
suppression of tumorigenicity 7 like |
chr7_+_127233689 | 0.46 |
ENST00000265825.5
ENST00000420086.2 |
FSCN3
|
fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) |
chr10_-_79397202 | 0.46 |
ENST00000372437.1
ENST00000372408.2 ENST00000372403.4 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr12_+_9144626 | 0.45 |
ENST00000543895.1
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1 |
chr13_+_32838801 | 0.45 |
ENST00000542859.1
|
FRY
|
furry homolog (Drosophila) |
chr5_+_74011328 | 0.45 |
ENST00000513336.1
|
HEXB
|
hexosaminidase B (beta polypeptide) |
chr7_+_77167343 | 0.44 |
ENST00000433369.2
ENST00000415482.2 |
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12 |
chr17_-_15502111 | 0.44 |
ENST00000354433.3
|
CDRT1
|
CMT1A duplicated region transcript 1 |
chr12_+_7023491 | 0.44 |
ENST00000541477.1
ENST00000229277.1 |
ENO2
|
enolase 2 (gamma, neuronal) |
chr9_-_118417 | 0.44 |
ENST00000382500.2
|
FOXD4
|
forkhead box D4 |
chr10_-_24770632 | 0.44 |
ENST00000596413.1
|
AL353583.1
|
AL353583.1 |
chr1_+_159409512 | 0.43 |
ENST00000423932.3
|
OR10J1
|
olfactory receptor, family 10, subfamily J, member 1 |
chr1_+_206579736 | 0.43 |
ENST00000439126.1
|
SRGAP2
|
SLIT-ROBO Rho GTPase activating protein 2 |
chr4_-_143227088 | 0.43 |
ENST00000511838.1
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chr5_+_140782351 | 0.43 |
ENST00000573521.1
|
PCDHGA9
|
protocadherin gamma subfamily A, 9 |
chr10_-_90712520 | 0.43 |
ENST00000224784.6
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
chr9_-_137809718 | 0.43 |
ENST00000371806.3
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1 |
chr2_+_201450591 | 0.43 |
ENST00000374700.2
|
AOX1
|
aldehyde oxidase 1 |
chr8_-_93029865 | 0.43 |
ENST00000422361.2
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr15_-_95870310 | 0.43 |
ENST00000508732.2
|
CTD-2536I1.1
|
CTD-2536I1.1 |
chr16_+_32264040 | 0.43 |
ENST00000398664.3
|
TP53TG3D
|
TP53 target 3D |
chr4_-_152149033 | 0.42 |
ENST00000514152.1
|
SH3D19
|
SH3 domain containing 19 |
chr7_+_1126437 | 0.42 |
ENST00000413368.1
ENST00000397092.1 |
GPER1
|
G protein-coupled estrogen receptor 1 |
chr5_+_147443534 | 0.41 |
ENST00000398454.1
ENST00000359874.3 ENST00000508733.1 ENST00000256084.7 |
SPINK5
|
serine peptidase inhibitor, Kazal type 5 |
chr17_-_40075197 | 0.41 |
ENST00000590770.1
ENST00000590151.1 |
ACLY
|
ATP citrate lyase |
chr9_+_124413873 | 0.41 |
ENST00000408936.3
|
DAB2IP
|
DAB2 interacting protein |
chr5_+_150639360 | 0.41 |
ENST00000523004.1
|
GM2A
|
GM2 ganglioside activator |
chr15_+_80733570 | 0.41 |
ENST00000533983.1
ENST00000527771.1 ENST00000525103.1 |
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2 |
chr16_-_72206034 | 0.41 |
ENST00000537465.1
ENST00000237353.10 |
PMFBP1
|
polyamine modulated factor 1 binding protein 1 |
chr9_-_131486367 | 0.41 |
ENST00000372663.4
ENST00000406904.2 ENST00000452105.1 ENST00000372672.2 ENST00000372667.5 |
ZDHHC12
|
zinc finger, DHHC-type containing 12 |
chr19_+_47105309 | 0.41 |
ENST00000599839.1
ENST00000596362.1 |
CALM3
|
calmodulin 3 (phosphorylase kinase, delta) |
chr2_-_219031709 | 0.41 |
ENST00000295683.2
|
CXCR1
|
chemokine (C-X-C motif) receptor 1 |
chr4_+_69962212 | 0.41 |
ENST00000508661.1
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
chr3_+_154797877 | 0.41 |
ENST00000462745.1
ENST00000493237.1 |
MME
|
membrane metallo-endopeptidase |
chr2_-_169746878 | 0.41 |
ENST00000282074.2
|
SPC25
|
SPC25, NDC80 kinetochore complex component |
chr17_-_64225508 | 0.40 |
ENST00000205948.6
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
chr20_-_48732472 | 0.40 |
ENST00000340309.3
ENST00000415862.2 ENST00000371677.3 ENST00000420027.2 |
UBE2V1
|
ubiquitin-conjugating enzyme E2 variant 1 |
chr7_+_134430212 | 0.40 |
ENST00000436461.2
|
CALD1
|
caldesmon 1 |
chr1_+_90098606 | 0.40 |
ENST00000370454.4
|
LRRC8C
|
leucine rich repeat containing 8 family, member C |
chr5_+_55033845 | 0.40 |
ENST00000353507.5
ENST00000514278.2 ENST00000505374.1 ENST00000506511.1 |
DDX4
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 |
chr3_+_169629354 | 0.40 |
ENST00000428432.2
ENST00000335556.3 |
SAMD7
|
sterile alpha motif domain containing 7 |
chr1_-_152131703 | 0.39 |
ENST00000316073.3
|
RPTN
|
repetin |
chr3_+_136537911 | 0.39 |
ENST00000393079.3
|
SLC35G2
|
solute carrier family 35, member G2 |
chr1_-_152552980 | 0.39 |
ENST00000368787.3
|
LCE3D
|
late cornified envelope 3D |
chr11_-_62323702 | 0.39 |
ENST00000530285.1
|
AHNAK
|
AHNAK nucleoprotein |
chr15_+_26360970 | 0.39 |
ENST00000556159.1
ENST00000557523.1 |
LINC00929
|
long intergenic non-protein coding RNA 929 |
chr1_-_193029192 | 0.39 |
ENST00000417752.1
ENST00000367452.4 |
UCHL5
|
ubiquitin carboxyl-terminal hydrolase L5 |
chr2_+_113816215 | 0.39 |
ENST00000346807.3
|
IL36RN
|
interleukin 36 receptor antagonist |
chr15_+_52121822 | 0.39 |
ENST00000558455.1
ENST00000308580.7 |
TMOD3
|
tropomodulin 3 (ubiquitous) |
chr7_+_1126461 | 0.39 |
ENST00000297469.3
|
GPER1
|
G protein-coupled estrogen receptor 1 |
chr3_-_48594248 | 0.39 |
ENST00000545984.1
ENST00000232375.3 ENST00000416568.1 ENST00000383734.2 ENST00000541519.1 ENST00000412035.1 |
PFKFB4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
chr15_+_66797627 | 0.39 |
ENST00000565627.1
ENST00000564179.1 |
ZWILCH
|
zwilch kinetochore protein |
chr10_-_101825151 | 0.39 |
ENST00000441382.1
|
CPN1
|
carboxypeptidase N, polypeptide 1 |
chr7_+_129932974 | 0.39 |
ENST00000445470.2
ENST00000222482.4 ENST00000492072.1 ENST00000473956.1 ENST00000493259.1 ENST00000486598.1 |
CPA4
|
carboxypeptidase A4 |
chrX_-_77225135 | 0.38 |
ENST00000458128.1
|
PGAM4
|
phosphoglycerate mutase family member 4 |
chr3_+_136537816 | 0.38 |
ENST00000446465.2
|
SLC35G2
|
solute carrier family 35, member G2 |
chr1_+_206223941 | 0.38 |
ENST00000367126.4
|
AVPR1B
|
arginine vasopressin receptor 1B |
chrX_-_55057403 | 0.38 |
ENST00000396198.3
ENST00000335854.4 ENST00000455688.1 ENST00000330807.5 |
ALAS2
|
aminolevulinate, delta-, synthase 2 |
chr11_-_5345582 | 0.38 |
ENST00000328813.2
|
OR51B2
|
olfactory receptor, family 51, subfamily B, member 2 |
chr6_+_72922590 | 0.38 |
ENST00000523963.1
|
RIMS1
|
regulating synaptic membrane exocytosis 1 |
chr1_+_24645807 | 0.38 |
ENST00000361548.4
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr17_-_40075219 | 0.38 |
ENST00000537919.1
ENST00000352035.2 ENST00000353196.1 ENST00000393896.2 |
ACLY
|
ATP citrate lyase |
chr11_+_69455855 | 0.38 |
ENST00000227507.2
ENST00000536559.1 |
CCND1
|
cyclin D1 |
chr12_-_11002063 | 0.38 |
ENST00000544994.1
ENST00000228811.4 ENST00000540107.1 |
PRR4
|
proline rich 4 (lacrimal) |
chr8_+_104831472 | 0.37 |
ENST00000262231.10
ENST00000507740.1 |
RIMS2
|
regulating synaptic membrane exocytosis 2 |
chrX_+_135614293 | 0.37 |
ENST00000370634.3
|
VGLL1
|
vestigial like 1 (Drosophila) |
chr19_+_51628165 | 0.37 |
ENST00000250360.3
ENST00000440804.3 |
SIGLEC9
|
sialic acid binding Ig-like lectin 9 |
chr4_+_72897521 | 0.37 |
ENST00000308744.6
ENST00000344413.5 |
NPFFR2
|
neuropeptide FF receptor 2 |
chrX_-_20074895 | 0.37 |
ENST00000543767.1
|
MAP7D2
|
MAP7 domain containing 2 |
chr15_-_80263506 | 0.37 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr11_+_126225789 | 0.37 |
ENST00000530591.1
ENST00000534083.1 |
ST3GAL4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
chr6_+_31553901 | 0.37 |
ENST00000418507.2
ENST00000438075.2 ENST00000376100.3 ENST00000376111.4 |
LST1
|
leukocyte specific transcript 1 |
chr1_+_95975672 | 0.36 |
ENST00000440116.2
ENST00000456933.1 |
RP11-286B14.1
|
RP11-286B14.1 |
chr19_+_7011509 | 0.36 |
ENST00000377296.3
|
AC025278.1
|
Uncharacterized protein |
chr5_+_180467219 | 0.36 |
ENST00000376841.2
ENST00000327705.9 ENST00000376842.3 |
BTNL9
|
butyrophilin-like 9 |
chrX_+_105192423 | 0.36 |
ENST00000540278.1
|
NRK
|
Nik related kinase |
chr1_+_202995611 | 0.36 |
ENST00000367240.2
|
PPFIA4
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 |
chr5_+_140767452 | 0.36 |
ENST00000519479.1
|
PCDHGB4
|
protocadherin gamma subfamily B, 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 4.0 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.4 | 0.4 | GO:0002784 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.3 | 0.8 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
0.2 | 2.6 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.2 | 0.9 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.2 | 0.7 | GO:0070632 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.2 | 0.6 | GO:0032499 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) |
0.2 | 2.1 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.2 | 1.3 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.2 | 0.6 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.2 | 0.9 | GO:0007619 | courtship behavior(GO:0007619) |
0.2 | 0.7 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.2 | 0.6 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.2 | 0.5 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 1.0 | GO:0097338 | response to clozapine(GO:0097338) |
0.1 | 0.4 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.1 | 0.9 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.4 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.1 | 1.0 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.4 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.1 | 1.1 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.5 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.1 | 0.4 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.1 | 0.5 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.1 | 0.4 | GO:0060721 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.1 | 0.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.4 | GO:2000213 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.1 | 0.6 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.1 | 0.6 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 0.3 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 0.5 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.1 | 0.4 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.1 | 0.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.9 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.5 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
0.1 | 0.3 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
0.1 | 0.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.8 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.4 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.8 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.9 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.1 | 0.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.5 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.9 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.3 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.1 | 0.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 0.6 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.1 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.5 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.3 | GO:0100009 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
0.1 | 0.3 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.1 | 0.4 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 0.4 | GO:0043553 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.3 | GO:1904647 | response to rotenone(GO:1904647) |
0.1 | 0.4 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.2 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.1 | 0.2 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.1 | 0.2 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.1 | 0.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.6 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.4 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of hydrogen peroxide catabolic process(GO:2000295) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
0.1 | 0.3 | GO:0002545 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
0.1 | 0.4 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 0.2 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.1 | 0.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.2 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.1 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.3 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.1 | 0.2 | GO:2000816 | negative regulation of mitotic sister chromatid separation(GO:2000816) |
0.1 | 0.2 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.1 | 0.2 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.1 | 0.3 | GO:0003138 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.1 | 0.4 | GO:2000683 | regulation of cellular response to X-ray(GO:2000683) |
0.1 | 1.2 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 1.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 3.0 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.1 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.1 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.1 | 0.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.1 | 1.0 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 0.5 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.1 | 0.3 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.1 | 0.2 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
0.1 | 0.9 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.2 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.1 | 0.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.2 | GO:2000329 | negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
0.1 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 1.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.1 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.1 | 0.3 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 0.2 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.1 | 0.1 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.0 | 0.3 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.0 | 0.1 | GO:1903487 | regulation of lactation(GO:1903487) |
0.0 | 0.7 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 1.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.1 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.0 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.1 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
0.0 | 2.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.0 | 0.4 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.3 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.0 | 0.7 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.2 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.2 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
0.0 | 0.7 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.0 | 0.1 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.3 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.1 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.0 | 0.2 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.2 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.0 | 0.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.0 | 0.3 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.0 | 0.1 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.0 | 0.4 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.0 | 0.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.2 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.0 | 0.3 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.0 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.1 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.0 | 0.4 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
0.0 | 0.3 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.5 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.1 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.0 | 0.2 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.0 | 0.2 | GO:1902713 | regulation of interferon-gamma secretion(GO:1902713) |
0.0 | 0.1 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.0 | 0.1 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.0 | 0.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 4.0 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.2 | GO:0001503 | ossification(GO:0001503) |
0.0 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.2 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
0.0 | 0.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.0 | 0.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.0 | 0.6 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.1 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.0 | 0.2 | GO:1904879 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.1 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.0 | 0.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.8 | GO:0098743 | cell aggregation(GO:0098743) |
0.0 | 0.2 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.0 | 0.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.6 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.3 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.0 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.6 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.4 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 1.1 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.9 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.2 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.0 | 0.3 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.1 | GO:0046849 | bone remodeling(GO:0046849) |
0.0 | 0.9 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.1 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.0 | 0.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 1.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) glycerophosphate shuttle(GO:0006127) |
0.0 | 0.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.0 | 0.1 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.0 | 0.1 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.0 | 0.1 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.0 | 0.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.4 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.2 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.1 | GO:0015811 | L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.0 | 0.5 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.0 | 0.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.1 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
0.0 | 1.1 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.2 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.1 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.0 | 0.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 0.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) regulation of branching morphogenesis of a nerve(GO:2000172) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 1.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.0 | 0.4 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.0 | 0.1 | GO:0045333 | cellular respiration(GO:0045333) |
0.0 | 0.1 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 0.3 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.3 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.2 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.0 | 0.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.0 | 0.2 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.0 | GO:1990637 | response to prolactin(GO:1990637) |
0.0 | 0.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.0 | 0.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.0 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.0 | 0.1 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.0 | 0.1 | GO:0048749 | compound eye development(GO:0048749) |
0.0 | 0.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.0 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.2 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.6 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.0 | 0.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.2 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.0 | 0.0 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.0 | 0.0 | GO:0099612 | protein localization to axon(GO:0099612) |
0.0 | 0.3 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.0 | 1.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.4 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 2.7 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 0.2 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.5 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.3 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.0 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.0 | 0.3 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.0 | 0.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.0 | 0.0 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.2 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.3 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.9 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.3 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.2 | GO:0015866 | ADP transport(GO:0015866) |
0.0 | 0.2 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.0 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.0 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.0 | 0.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.1 | GO:1904871 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
0.0 | 0.0 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 0.1 | GO:0032439 | endosome localization(GO:0032439) positive regulation of pinocytosis(GO:0048549) |
0.0 | 0.7 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.0 | 0.2 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.3 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.2 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 4.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.3 | 1.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.7 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
0.2 | 0.5 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.2 | 0.5 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.1 | 0.4 | GO:1990032 | parallel fiber(GO:1990032) |
0.1 | 0.5 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 0.5 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.5 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.8 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 1.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.4 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.1 | 2.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
0.1 | 0.6 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 1.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 2.1 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.4 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.5 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 0.2 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.1 | 0.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 3.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 1.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.7 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.2 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 2.5 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.0 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.0 | 0.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 1.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.3 | GO:0016013 | syntrophin complex(GO:0016013) |
0.0 | 1.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.3 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.3 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.0 | 1.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.2 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.0 | 0.1 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.0 | 0.1 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 1.2 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.2 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.1 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.0 | 0.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.1 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 1.0 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.1 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.0 | 0.4 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) endolysosome membrane(GO:0036020) |
0.0 | 0.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.4 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.0 | 0.1 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 1.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.2 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 1.5 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 1.8 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.0 | GO:0044609 | DBIRD complex(GO:0044609) |
0.0 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.0 | GO:0031905 | early endosome lumen(GO:0031905) |
0.0 | 1.0 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.2 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.3 | GO:0097228 | sperm principal piece(GO:0097228) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.6 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.3 | 0.9 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.3 | 1.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 0.8 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.2 | 0.9 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.2 | 1.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 2.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 0.5 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.2 | 0.9 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.2 | 0.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.7 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.4 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 0.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.4 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.6 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 0.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.4 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.1 | 0.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.3 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.1 | 0.5 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.1 | 0.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.6 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 0.9 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.5 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.1 | 0.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.4 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 1.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 1.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.3 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 0.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.3 | GO:0061598 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.1 | 0.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.6 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.4 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.1 | 0.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 1.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 2.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.3 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.1 | 0.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.2 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.1 | 0.2 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.1 | 0.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.2 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
0.1 | 0.2 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.1 | 0.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.3 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.5 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 1.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 1.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.2 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.1 | 0.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.0 | 0.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0008431 | vitamin E binding(GO:0008431) |
0.0 | 0.1 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.0 | 0.1 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
0.0 | 0.1 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.0 | 0.2 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 1.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.0 | 1.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.0 | 0.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.1 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.2 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.0 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 1.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.1 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.2 | GO:0070905 | serine binding(GO:0070905) |
0.0 | 0.2 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.2 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0070404 | NADH binding(GO:0070404) |
0.0 | 0.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.0 | 0.4 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.0 | 0.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.1 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.0 | 0.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 1.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.0 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.0 | 0.1 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.0 | 0.2 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.0 | 0.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 2.7 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 0.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 6.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.0 | 2.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.0 | 0.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.0 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.1 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.4 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) acetylcholine binding(GO:0042166) |
0.0 | 0.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.4 | GO:0008527 | taste receptor activity(GO:0008527) bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.0 | 0.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.5 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.1 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.4 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.1 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.0 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 1.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.6 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 1.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 1.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.2 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.0 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 1.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 1.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 2.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 1.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 1.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 1.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 2.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 3.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.8 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 1.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 1.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 1.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 1.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 1.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |